Kidney Injury, Dialysis, and Mortality with Vancomycin Plus Piperacillin-Tazobactam or Cefepime.
Saved in:
| Title: | Kidney Injury, Dialysis, and Mortality with Vancomycin Plus Piperacillin-Tazobactam or Cefepime. |
|---|---|
| Authors: | Magagnoli J; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina; Center for Outcomes Research and Evaluation (CORE) College of Pharmacy, University of South Carolina, Columbia, South Carolina. Electronic address: magagnol@mailbox.sc.edu., Cummings TH; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina; Center for Outcomes Research and Evaluation (CORE) College of Pharmacy, University of South Carolina, Columbia, South Carolina., Bland CM; Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Savannah, Georgia., Sutton SS; Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina; Center for Outcomes Research and Evaluation (CORE) College of Pharmacy, University of South Carolina, Columbia, South Carolina. |
| Source: | International journal of antimicrobial agents [Int J Antimicrob Agents] 2026 Jun 26, pp. 107897. Date of Electronic Publication: 2026 Jun 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
